Literature DB >> 15310500

Basic aspects of melatonin action.

D P Cardinali1, P Pévet.   

Abstract

Melatonin is synthesized and secreted during the dark period of the light-dark cycle. Thus, melatonin has an obvious association with sleep, at least in diurnal animals. Rhythmic nocturnal melatonin secretion is directly generated by the circadian clock, located in mammals within the suprachiasmatic nuclei (SCN), and is entrained to a 24-h period by the light-dark cycle. The periodic secretion of melatonin may be used as a circadian mediator to any system than can "read" the message. In addition, direct effects of the hormone on the SCN could explain some of melatonin effects on the circadian system. Duration of melatonin nocturnal secretion is directly proportional to the length of the night and it has been demonstrated experimentally to be the critical parameter for photoperiod integration. The two main hypotheses to explain the action of melatonin are the duration hypothesis (supporting that night length is coded by the duration of the melatonin secretory phase) and the coincidence hypothesis (holding that physiological responses are linked to the existence of a diurnal rhythm in sensitivity to melatonin). The sites and mechanisms of action of melatonin for circadian and photoperiodic responses are far from being elucidated, but action through specific membrane receptor sites is well documented. In view of melatonin s lipophilic nature, interactions with specific intracellular proteins like calmodulin or tubulin, or with nuclear receptor sites, have also been considered, whereas the physiological significance of the documented antioxidant effect of melatonin remains to be settled. Melatonin seems to act as an "arm" of the circadian clock, giving a time-related signal to a number of body functions; one of these, the circadian organization of an organism's defence, is discussed in some detail as an example.

Entities:  

Year:  1998        PMID: 15310500     DOI: 10.1016/s1087-0792(98)90020-x

Source DB:  PubMed          Journal:  Sleep Med Rev        ISSN: 1087-0792            Impact factor:   11.609


  33 in total

Review 1.  Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.

Authors:  Seithikurippu R Pandi-Perumal; Ahmed S BaHammam; Gregory M Brown; D Warren Spence; Vijay K Bharti; Charanjit Kaur; Rüdiger Hardeland; Daniel P Cardinali
Journal:  Neurotox Res       Date:  2012-06-28       Impact factor: 3.911

2.  General anesthesia for surgery influences melatonin and cortisol levels.

Authors:  Edward Ram; Tali H Vishne; Talia Weinstein; Benzion Beilin; Zeev Dreznik
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

3.  Effects of melatonin and gonadal androgens on cell proliferation in the pituitary of viscachas (Lagostomus maximus maximus).

Authors:  G J Rosales; F I Busolini; F H Mohamed; V P Filippa
Journal:  Cell Prolif       Date:  2016-08-03       Impact factor: 6.831

4.  Relation of melatonin to sleep architecture in children with autism.

Authors:  Roberta M Leu; Liya Beyderman; Emmanuel J Botzolakis; Kyla Surdyka; Lily Wang; Beth A Malow
Journal:  J Autism Dev Disord       Date:  2011-04

Review 5.  Role of melatonin in neurodegenerative diseases.

Authors:  V Srinivasan; S R Pandi-Perumal; G Jm Maestroni; A I Esquifino; R Hardeland; D P Cardinali
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

6.  Measuring serum melatonin in epidemiologic studies.

Authors:  Ann W Hsing; Tamra E Meyer; Shelley Niwa; Sabah M Quraishi; Lisa W Chu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-23       Impact factor: 4.254

7.  Effect of melatonin on changes in locomotor activity rhythm of Syrian hamsters injected with beta amyloid peptide 25-35 in the suprachiasmatic nuclei.

Authors:  Analía M Furio; Rodolfo A Cutrera; Víctor Castillo Thea; Santiago Pérez Lloret; Patricia Riccio; Roberto L Caccuri; Luis L Brusco; Daniel P Cardinali
Journal:  Cell Mol Neurobiol       Date:  2002-12       Impact factor: 5.046

Review 8.  Role of the melatonin system in the control of sleep: therapeutic implications.

Authors:  Seithikurippu R Pandi-Perumal; Venkatramanujan Srinivasan; D Warren Spence; Daniel P Cardinali
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

9.  Effect of melatonin on the severity of L-arginine-induced experimental acute pancreatitis in rats.

Authors:  Annamaria Szabolcs; Russel J Reiter; Tamas Letoha; Peter Hegyi; Gabor Papai; Ilona Varga; Katalin Jarmay; Jozsef Kaszaki; Reka Sari; Zoltan Rakonczay; Janos Lonovics; Tamas Takacs
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

10.  Low urinary 6-sulfatoxymelatonin levels in patients with severe congestive heart failure.

Authors:  Luis Girotti; Manuel Lago; Oscar Ianovsky; Marcelo V Elizari; Andrés Dini; Santiago Pérez Lloret; Liliana E Albornoz; Daniel P Cardinali
Journal:  Endocrine       Date:  2003-12       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.